Knockout cells are genetically engineered cells in which specific genes have been permanently inactivated or deleted. These experimental models are indispensable tools in neurodegeneration research, enabling researchers to elucidate gene function, model disease mechanisms, and test therapeutic interventions. The ability to ablate specific genes provides critical insights into the molecular pathways underlying Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
| Property |
Value |
| Category |
Research Tools |
| Application |
Gene function studies, disease modeling |
| Technology |
Homologous recombination, CRISPR-Cas9 |
| Organisms |
Mouse, rat, zebrafish, cell lines |
- Global deletion: Gene inactivated in all tissues throughout development
- Advantages: Complete loss-of-function analysis
- Limitations: May cause embryonic lethality or developmental compensation
- Example: APP knockout mice used to study amyloid metabolism
- Temporal control: Gene deleted at specific times using inducible systems
- Spatial control: Gene removed in specific cell types using Cre-loxP
- Advantages: Study adult-onset gene functions without developmental effects
- Example: Tau deletion in adult neurons to separate developmental from disease roles
- Point mutations: Specific amino acid changes introduced
- Humanized knock-ins: Replace mouse gene with human ortholog
- Reporter knock-ins: Add fluorescent tags for visualization
- Example: Knock-in of pathogenic APP mutations for AD modeling
- Cell lines: Cultured cells with gene deletions
- iPSC-derived neurons: Patient-specific cells with corrected or knockout genes
- Organoids: 3D cell cultures with specific knockouts
- Advantages: Human disease modeling, high-throughput screening
- APP knockout: Reveals APP-independent amyloid effects
- ApoE knockout: Studies isoform-specific lipid transport functions
- TREM2 knockout: Examines microglial dysfunction in AD
- Presenilin knockout: Dissects gamma-secretase independent functions
- Alpha-synuclein knockout: Reveals physiological protein function
- LRRK2 knockout: Studies kinase-dependent and independent effects
- PINK1 knockout: Mitochondrial quality control mechanisms
- Parkin knockout: Ubiquitin-proteasome system in PD
- SOD1 knockout: Distinguished gain-of-function from loss-of-function
- C9orf72 knockout: Repeat expansion independent functions
- TDP-43 knockout: RNA metabolism and stress granule dynamics
- FUS knockout: Nuclear import/export abnormalities
- Huntingtin knockout: Essential versus disease-causing functions
- Mutant huntingtin knockin: Accurate disease modeling
- CAG repeat length effects: Progressive phenotype development
- Embryonic lethality: ~15% of genes essential for development
- Workarounds: Conditional knockouts, heterozygous analysis
- Phenotypic masking: Developmental compensation mechanisms
- Strain effects: Phenotype severity varies with genetic background
- C57BL/6 vs. 129: Common strain differences
- Congenic lines: Backcrossing to standardize background
- Genetic redundancy: Related genes may compensate
- Upregulation: Neighboring genes may increase expression
- Adaptation: Cellular pathways may rewire
- Efficiency: High-frequency targeting in most cell types
- Multiplexing: Multiple genes targeted simultaneously
- Base editing: Precise nucleotide changes without double-strand breaks
- Prime editing: All types of mutations with high precision
- CRISPRi: Knockdown via transcriptional interference
- CRISPRa: Overexpression via transcriptional activation
- Temporal control: dCas9 fusions for inducible regulation
- Reversible: Can be turned on/off as needed
- Loss-of-function studies: Determine if gene reduction is beneficial
- Synthetic lethality: Identify vulnerabilities in disease cells
- Pathway dissection: Deconstruct disease mechanisms
- Knockout cell libraries: Genome-wide screening platforms
- Phenotypic screens: Identify compounds that rescue knockout phenotypes
- Mechanism of action: Determine how drugs work at molecular level
- Allele-specific targeting: Mutant allele knockout only
- outs: RegConditional knockulate timing of therapeutic intervention
- Combination approaches: Multiple targets simultaneously
The study of Knockout Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Knockout mice in neurodegeneration research
- CRISPR applications in neurodegenerative disease modeling
- Conditional gene targeting in the nervous system
- iPSC-derived neurons with genetic corrections
- Genome-wide CRISPR screens in neurodegeneration